У нас вы можете посмотреть бесплатно March 2025 Genomics PSCM CoP ECHO: establishing more inclusive Service Level Agreements (SLAs) или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
26th March 2025, This fourth Genomic Sequencing CoP ECHO session focused on establishing more inclusive Service Level Agreements (SLAs) for genomic sequencing equipment in Africa Current Genomic Sequencing (GS) equipment Service Level Agreements (SLAs) in most African countries are fragmented, lacking transparency and standardization. Many SLAs focus on limited deliverable metrics without clear key performance indicators (KPIs) for accountability or performance evaluation. These gaps lead to unforeseen costs, prolonged equipment downtime, and disruptions in laboratory operations for clinical diagnostics, public health surveillance, and research. To address these issues, Africa CDC advocates for Required Minimum Service Level Agreement (RMSLA) terms and has developed an advocacy note to establish benchmark service and maintenance standards for manufacturers. Additionally, developing and implementing inclusive, comprehensive SLAs with clearly defined service parameters, performance metrics, responsibilities, and cost structures is essential to ensuring equitable access to reliable sequencing equipment services Objective: This session explored the development of standardized inclusive SLAs terms for GS equipment to ensure regional and institutional equitable access to service and maintenance while fostering collaboration among stakeholders to enhance sustainability and service reliability. Session Key Topics 1. Key Advocacy Points for action in Genomic Sequencing PSM (By AfCDC) 2. Overview of inclusive SLA Terms (By CHAI) • Establishing minimum SLAs: Terms, Conditions and benefits • Tracking SLAs implementation 3. Discussions (By All) Target Audience: • GS Equipment Suppliers, Manufacturers, and Channel Partners. • Genomic Sequence consumers (such as GS laboratories) Expected Session Outcomes: • Stakeholder feedback and recommendations for refining SLA terms. • Insights into key implementation enablers and barriers Moderator: • Nyasha Sithole, Project Coordinator, ASLM Presenter: • Julia Tuttle, Senior Program Manager Global Diagnostics Team, Clinton Health Access Initiative (CHAI)